Format

Send to

Choose Destination
Amyotroph Lateral Scler. 2008 Dec;9(6):321-2. doi: 10.1080/17482960802425559.

Is it too soon for mesenchymal stem cell trials in people with ALS?

Author information

1
Neurology Clinical Trials Unit, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. ibadayan@partners.org

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting primarily the motor neurons. Stem cell therapy is under development as a possible treatment approach. A pilot study of intraspinal injections of mesenchymal stem cells (MSC) was conducted in 9 participants. We review this paper, the rationale, preclinical data and study design.

Comment in

PMID:
18819027
DOI:
10.1080/17482960802425559
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center